On February 22, the Department of Justice (DOJ) released its annual report of civil fraud recoveries for FY2023, along with a press release highlighting DOJ’s civil enforcement efforts.
Our top ten observations from...more
2/26/2024
/ Annual Reports ,
Anti-Kickback Statute ,
Controlled Substances Act ,
Cybersecurity ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Enforcement Statistics ,
False Claims Act (FCA) ,
Fraud ,
Fraud and Abuse ,
Healthcare ,
Opioid ,
Qui Tam ,
Relators
The FCA continues to be the federal government’s primary civil enforcement tool for investigating allegations that healthcare providers or government contractors defrauded the federal government. In the coming weeks, we...more
6/24/2017
/ Amended Complaints ,
Drug Pricing ,
False Claims Act (FCA) ,
Federal Contractors ,
FOIA ,
Fraud ,
Health Care Providers ,
Level of Generality Test ,
Public Disclosure ,
Qui Tam ,
Relators
The government’s FCA enforcement efforts have continued to focus on key areas concerning the pharmaceutical and medical device industries. In fact, drug and device manufacturers accounted for nearly half of the enforcement...more
5/16/2017
/ Anti-Kickback Statute ,
Discount Pricing ,
False Claims Act (FCA) ,
Fraud ,
GlaxoSmithKline ,
Health Insurance ,
Medical Devices ,
Off-Label Promotion ,
Pfizer ,
Pharmaceutical Industry ,
Pharmacies ,
Physicians ,
Prescription Drugs ,
RICO
The FCA continues to be the federal government’s primary civil enforcement tool for investigating allegations that healthcare providers or government contractors defrauded the federal government. In the coming weeks, we are...more